NASDAQ:BCPCBalchem Stock Price, Forecast & News

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BCPC stock has increased by 5.7% and is now trading at $94.35. View which stocks have been most impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Balchem.

Balchem is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Balchem.

Balchem Co. (NASDAQ:BCPC) released its earnings results on Friday, May, 1st. The basic materials company reported $0.81 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.59 by $0.22. The basic materials company had revenue of $174.44 million for the quarter, compared to analysts' expectations of $169.87 million. Balchem had a net margin of 12.20% and a return on equity of 14.30%. Balchem's revenue was up 11.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.73 earnings per share. View Balchem's earnings history.

Balchem declared an annual dividend on Wednesday, December 18th. Shareholders of record on Monday, December 30th will be given a dividend of $0.52 per share on Friday, January 17th. This represents a dividend yield of 0.51%. The ex-dividend date is Friday, December 27th. This is a boost from Balchem's previous annual dividend of $0.47. View Balchem's dividend history.

2 analysts have issued 12 month target prices for Balchem's shares. Their forecasts range from $100.00 to $104.00. On average, they anticipate Balchem's stock price to reach $102.00 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price. View analysts' price targets for Balchem.

Headlines about BCPC stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Balchem earned a media sentiment score of -3.8 on InfoTrie's scale. They also gave media headlines about the basic materials company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Balchem.

Balchem saw a decrease in short interest in June. As of June 30th, there was short interest totaling 493,100 shares, a decrease of 8.7% from the June 15th total of 540,000 shares. Based on an average daily volume of 173,600 shares, the days-to-cover ratio is currently 2.8 days. Approximately 1.5% of the shares of the company are short sold. View Balchem's Current Options Chain.

Some companies that are related to Balchem include Ecolab (ECL), Sherwin-Williams (SHW), International Flavors & Fragrances (IFF), Celanese (CE), RPM International (RPM), Albemarle (ALB), NewMarket (NEU), Ashland Global (ASH), Quaker Chemical (KWR), W. R. Grace & Co (GRA), PolyOne (POL), Sensient Technologies (SXT), HB Fuller (FUL), Stepan (SCL) and Innospec (IOSP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Gilead Sciences (GILD), AbbVie (ABBV), CVS Health (CVS), Ecolab (ECL), Adobe (ADBE), Mastercard (MA), Altria Group (MO), NVIDIA (NVDA), Pfizer (PFE) and Starbucks (SBUX).

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Balchem's stock is owned by a variety of institutional and retail investors. Top institutional investors include Bath Savings Trust Co (0.16%), Envestnet Asset Management Inc. (0.11%), State of Alaska Department of Revenue (0.09%) and Everence Capital Management Inc. (0.02%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason. View institutional ownership trends for Balchem.

BCPC stock was sold by a variety of institutional investors in the last quarter, including Bath Savings Trust Co, and Envestnet Asset Management Inc.. View insider buying and selling activity for Balchem.

BCPC stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, and Everence Capital Management Inc.. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason. View insider buying and selling activity for Balchem.

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCPC stock can currently be purchased for approximately $94.35.

Balchem has a market capitalization of $3.05 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

The official website for Balchem is www.balchem.com.

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]